S100A1 and pulmonary fibrosis: These insights suggest S100 proteins could serve as biomarkers for disease severity, prognosis, and therapeutic response; for instance, high levels of S100A8/A9 may indicate severe COVID-19 or pulmonary fibrosis, and S100A12 and S100A8/A9 can help monitor graft rejection in lung transplant patients.